InvestorsHub Logo
Followers 0
Posts 64
Boards Moderated 0
Alias Born 03/24/2008

Re: n4807g post# 4729

Wednesday, 08/02/2017 11:27:01 AM

Wednesday, August 02, 2017 11:27:01 AM

Post# of 7747
Approval extremely likely with such postive response on FDA meeting.
Oncologists not switching to the safer more effective form will be taking on enormous malpractice risk-especially if heart failure occurs. Transition will be rapid- much better choice for patients- an defensive medicine for themselves.